Sudhamshi Toom is an Oncology physician affiliated with UPMC Hillman Cancer Center. OpenAlex indexes 23 publications with 967 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Erford Rd
Camp Hill, PA 170111802
Telephone
179-758-9007Provider last certified this registry record 4 Apr 2022.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20254 payments
- Gilead Sciences, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
41.7%Aromatase Inhibitor22.3%Anastrozole89%Exemestane6%Letrozole6%Part D<11 patientsKinase inhibitor6.2%Verzenio35%Imatinib Mesylate20%Ibrance17%Calquence15%Jakafi13%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
25.5%Serotonin-3 Receptor Antagonist6.9%Ondansetron Hcl88%Ondansetron Odt12%Part D<11 patientsH2 blocker6.2%Famotidine100%Part D≥27 patients+ 5 more classes in this area
Nervous system
11.3%Phenothiazine6.4%Prochlorperazine Maleate100%Part D≥59 patientsGabapentinoids2%Gabapentin100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Secretory Carcinoma of the Breast Mimicking Invasive Ductal Carcinoma: A Case Report
American Journal of Case Reports
2022 - Unusual prevalence of cancer genetic mutations in a cohort of predominantly non-Caucasian cancer patients.
Journal of Clinical Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Udai Kammula, MD
UPMC Hillman Cancer Center
Amer Zureikat, MD
UPMC Hillman Cancer Center
Antoinette Wozniak, MD
UPMC Hillman Cancer Center
Mounzer Agha, MD
UPMC Hillman Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”